Residency · Residency · Obstetrics Gynecology

Permanent Sterilization: Counseling and Techniques

Introduction

Permanent sterilization is one of the most common contraceptive methods used worldwide. Female sterilization accounts for approximately 27% of contraceptive use among married or cohabiting women globally. Thorough counseling, informed consent, and technical proficiency are essential. The shift from tubal occlusion to bilateral salpingectomy as the preferred method has been driven by emerging evidence regarding ovarian cancer risk reduction.

Preoperative Counseling

Informed Consent

The permanence of sterilization must be emphasized. While reversal and IVF are options, success is not guaranteed and both are costly. Risk factors for regret include age under 30 years (the highest regret rate, reaching up to 20%), making the decision during times of stress such as marital conflict or pregnancy, concurrent Cesarean delivery, limited parity, and lack of partner support. The CREST study found that the cumulative 14-year probability of regret was 12.7% overall, 20.3% for women aged 18 to 24 at the time of sterilization, and 5.9% for those over 30. Alternatives should be comprehensively discussed, particularly LARC methods, which offer equivalent efficacy with reversibility. Federal regulations for Medicaid sterilization consent require a 30-day waiting period between consent and procedure (72 hours for emergency situations), the patient must be at least 21 years old, and specific consent documentation must be completed. These regulations do not apply to privately insured patients. Regarding failure rates, bilateral salpingectomy has a near-zero failure rate, while tubal ligation has a 10-year failure rate of 1.85% per the CREST study, with the highest rate seen with clip application at 3.65% over 10 years.

Method Selection

Bilateral salpingectomy is now the preferred method per ACOG, SGO, and NSGC guidelines due to the added benefit of ovarian cancer risk reduction. Tubal ligation (occlusion) remains an option and may be preferred in certain clinical scenarios, such as postpartum minilaparotomy when salpingectomy is technically challenging. Vasectomy should be discussed as male sterilization is safer, less invasive, and less costly than female sterilization and can be performed in the office under local anesthesia.

<image>Comparative illustration showing different methods of female sterilization including bilateral salpingectomy (complete tube removal), Pomeroy method (tubal ligation with mid-isthmic excision), Falope ring application, and Filshie clip placement, with labeled anatomical landmarks</image>

Surgical Techniques

Bilateral Salpingectomy

The rationale for salpingectomy is the accumulating evidence that high-grade serous ovarian carcinoma, the most common and lethal subtype, originates in the fimbriated end of the fallopian tube from serous tubal intraepithelial carcinoma (STIC) lesions. Observational studies demonstrate a 40 to 65% reduction in ovarian cancer risk with opportunistic salpingectomy. The technique involves identifying the tube from the fimbriated end to the cornua, creating a window in the mesosalpinx close to the tube, sequentially coagulating and dividing the mesosalpinx using bipolar electrosurgery or an energy device, excising the tube at its insertion into the uterine cornua, and removing the specimen for pathologic examination. Current evidence indicates that salpingectomy does not significantly affect ovarian reserve (as measured by AMH and antral follicle count) or age at menopause. It can be performed laparoscopically as an interval procedure, via minilaparotomy in the postpartum period, or at the time of Cesarean delivery.

Tubal Ligation Methods

Postpartum minilaparotomy uses an infraumbilical incision when the uterine fundus is at the umbilicus. The Pomeroy or modified Pomeroy technique involves ligating and excising a loop of mid-isthmic tube, and is typically performed within 24 to 48 hours of vaginal delivery. In the Pomeroy technique, a loop of tube is elevated, the base is ligated with absorbable suture, and the knuckle is excised. As the suture absorbs, the tubal ends separate. Laparoscopic occlusion methods include bipolar electrosurgery (coagulating 3 cm of isthmic tube), the Falope ring (a silastic band applied to a knuckle of tube), and the Filshie clip (a single titanium and silicone clip applied to the isthmus). Excised tubal segments should always be sent for histologic confirmation.

Interval Laparoscopic Sterilization

Interval sterilization is performed at any time unrelated to pregnancy, typically in the follicular phase to minimize the risk of a luteal-phase pregnancy. General anesthesia is standard, though conscious sedation with local anesthesia is possible at experienced centers. The procedure uses single or dual port entry, with complete identification of bilateral tubes, followed by bilateral salpingectomy (preferred) or tubal occlusion. Most patients are discharged within 2 to 4 hours.

<image>Surgical view through laparoscope showing bilateral salpingectomy technique with bipolar electrosurgery device coagulating the mesosalpinx, demonstrating sequential devascularization from the fimbriated end toward the uterine cornua with labeled structures</image>

Sterilization at the Time of Cesarean Delivery

Consent should be obtained well in advance, and the Medicaid 30-day consent rule applies. The technique involves bilateral salpingectomy or Pomeroy tubal ligation through the existing hysterotomy incision. Salpingectomy at Cesarean is feasible and does not significantly increase operative time (averaging 10 to 15 additional minutes), blood loss, or complications. All tubal specimens should be submitted for pathology, as STIC lesions are identified in approximately 0.6 to 1% of salpingectomy specimens.

Postoperative Care

Return to normal activity occurs within 1 to 2 days for minilaparotomy and about 1 week for laparoscopic procedures. Sterilization is effective immediately, and no backup method is needed. A routine postoperative visit at 2 to 4 weeks is scheduled, with a pregnancy test if there is any concern for a luteal-phase pregnancy at the time of surgery. If pregnancy occurs after tubal ligation, 15 to 65% may be ectopic depending on the method used. Ectopic pregnancy must always be evaluated in sterilized women with a positive pregnancy test.

Sterilization Reversal

Success rates for reversal depend on the method used, the length of remaining tube (4 cm or greater is optimal), patient age, and surgeon experience. The overall intrauterine pregnancy rate after reversal ranges from 40 to 85%. The best candidates are younger women who had reversal of clip or ring methods, which cause less tubal destruction, and who have adequate remaining tubal length. IVF is an alternative with per-cycle success rates of 40 to 50% in women under 35 and may be preferred for women over 38 or those with additional fertility factors. Reversal is typically not covered by insurance, and IVF may be more cost-effective depending on individual circumstances.

Clinical Pearls

Bilateral salpingectomy should be offered as the preferred method of permanent sterilization to provide the dual benefit of contraception and ovarian cancer risk reduction.

Medicaid sterilization consent requires a 30-day waiting period, patient age of 21 or older, and specific consent documentation. This timeline must be anticipated for scheduled procedures.

Regret is most common in women sterilized before age 30. Thorough counseling including discussion of LARC alternatives is essential.

Vasectomy should always be discussed as a safer, simpler alternative to female sterilization during counseling.

If pregnancy occurs after tubal ligation, ectopic pregnancy must be evaluated promptly given the significantly elevated risk.

References

1. ACOG Committee Opinion No. 774. Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention. Obstet Gynecol. 2019;133(4):e279-e284.
2. Peterson HB, Xia Z, Hughes JM, et al. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization (CREST). Am J Obstet Gynecol. 1996;174(4):1161-1170.
3. Hanley GE, Pearce CL, Talhouk A, et al. Outcomes from opportunistic salpingectomy for ovarian cancer prevention. JAMA Netw Open. 2022;5(2):e2147343.
4. Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65(3):1-103.

Read this lecture as Markdown